Skip navigation
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
Prevention Among Injection Drug Users
 IDU HIV Prevention

Archive archive

 IDU Home
 Fact Sheets:
 Syringe Disinfection
 Sterile Syringes
 Viral Hepatitis
 Subst. Abuse
Treatment
 Criminal Justice
 Order Printed Materials
 Dear Colleague Letters
 Other Publications
 Comprehensive
Approach
 Brochure
 Document
 Safe Community Syringe Disposal
Explore IDU Topics
Comments
  Legend
Link to a PDF document Link to a PDF document
Link to a Non-CDC site
Link to non-CDC site or document and does not necessarily represent the views of CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
U.S. Department of Health and Human Services

Archival Content: 1999-2005

HIV Prevention Among Drug Users:
A Resource Book for Community Planners & Program Managers


Key Questions for HIV Prevention Planners and Program Managers

The following key questions related to PART 2 may help prevention planners and program managers select and implement more effective programs for drug users and their sex partners:

  • What kind of information is available from national, state, and local sources (e.g., health departments, academic institutions) on HIV seroprevalence, surrogate markers, drug use, and risk behaviors among drug users?
  • What data do we have about HIV in IDUs? In crack users? What are the strengths and limitations of the information?
  • What do we know about HIV risk behaviors and drug use in populations at risk, including women, particularly those who exchange sex for drugs and money, MSM and bisexual men, the homeless/mentally ill, or incarcerated or paroled individuals?
  • What are the social settings and networks that may increase HIV risk among drug users in the community?
  • Are shooting galleries and/or crack houses common in the community or do users more commonly gather in private settings (e.g., cars)?
  • Who among the drug user community are the key points for communication with other drug users?
  • How can we initiate locally relevant data gathering in collaboration with other local, state, and national organizations, or as part of other ongoing surveys and studies?
  • Who should be involved in gathering and reviewing available information and determining program priorities?
View PDFPDF Icon

This CDC Web site is no longer being reviewed or updated and thus is no longer kept current. This site remains to assist researchers or others needing historical content.

   
Go to top

Privacy Policy | Accessibility

USA.gov: The U.S. Government's Official Web Portal